Literature DB >> 15909260

Acute otitis media due to penicillin-nonsusceptible Streptococcus pneumoniae before and after the introduction of the pneumococcal conjugate vaccine.

M Catherine McEllistrem1, Jennifer M Adams, Kartik Patel, Aaron B Mendelsohn, Sheldon L Kaplan, John S Bradley, Gordon E Schutze, K S Kim, Edward O Mason, Ellen R Wald.   

Abstract

BACKGROUND: The impact of the 7-valent pneumococcal conjugate vaccine (PCV7 [Prevnar]) on penicillin-nonsusceptible Streptococcus pneumoniae (PNSP) recovered from children with acute otitis media (AOM) is unclear.
METHODS: At 5 hospitals, 505 pneumococcal isolates were collected from children with AOM between 1 January 1999 and 31 December 2002. Molecular subtyping was performed on 158 isolates.
RESULTS: Overall, the percentage of AOM cases due to non-PCV7 serogroups (including serotype 3) increased over time (from 12% in 1999 to 32% in 2002; P < .01) and according to the number of PCV7 doses received (18% [< or = 1 dose] vs. 35% [2-4 doses]; P < .01). The percentage of cases due to vaccine-related serotypes (including serotype 19A) increased according to the number of PCV7 doses received (10% [< or = 1 dose] vs. 19% [2-4 doses]; P = .05) but not over time, whereas the percentage of cases due to serotype 19F remained unchanged both over time and according to the number of PCV7 doses received. The frequency of penicillin nonsusceptibility among PCV7 serotypes (range, 65%-75%) and non-PCV7 serogroups (range, 11%-27%) did not significantly change overall. Although no change was detected among isolates collected from children with spontaneous drainage, the percentage of pneumococci recovered at the time of myringotomy and/or tympanostomy tube placement that were nonresistant to penicillin decreased over time (from 73% in 1999 to 53% in 2002; P = .03). All of the serotype 3 strains were genetically related, whereas 88% of the isolates that were either serotype 19F or serotype 23F were related to 1 of 3 international clones.
CONCLUSIONS: Among children with AOM, the proportion of cases due to non-PCV7 serogroups increased, vaccine-related serotypes increased, and serotype 19F remained unchanged. Although a decrease in the proportion of cases due to PNSP occurred among children who required myringotomy and/or tympanostomy tube placement, the proportion of PNSP remained unchanged overall and among children with spontaneous drainage. Because future trends in the susceptibility patterns of pneumococcal isolates recovered from children with AOM are not easy to predict, continued surveillance is essential.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15909260     DOI: 10.1086/429908

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  39 in total

1.  Contribution of serotype and genetic background to virulence of serotype 3 and serogroup 11 pneumococcal isolates.

Authors:  Lauren J McAllister; Abiodun D Ogunniyi; Uwe H Stroeher; Amanda J Leach; James C Paton
Journal:  Infect Immun       Date:  2011-09-19       Impact factor: 3.441

2.  Decline and rise of the antimicrobial susceptibility of Streptococcus pneumoniae isolated from middle ear fluid in children: influence of changes in circulating serotypes.

Authors:  Emilio Pérez-Trallero; José M Marimón; Marta Alonso; María Ercibengoa; José M García-Arenzana
Journal:  Antimicrob Agents Chemother       Date:  2012-04-30       Impact factor: 5.191

3.  Genetic basis for the new pneumococcal serotype, 6C.

Authors:  In Ho Park; Saeyoung Park; Susan K Hollingshead; Moon H Nahm
Journal:  Infect Immun       Date:  2007-06-18       Impact factor: 3.441

Review 4.  Vaccine-induced pathogen strain replacement: what are the mechanisms?

Authors:  Maia Martcheva; Benjamin M Bolker; Robert D Holt
Journal:  J R Soc Interface       Date:  2008-01-06       Impact factor: 4.118

5.  Epidemiologic and clinical implications of second-generation pneumococcal conjugate vaccines.

Authors:  Carmen Muñoz-Almagro; Adoracion Navarro-Torne; Roman Pallares
Journal:  Curr Infect Dis Rep       Date:  2013-04       Impact factor: 3.725

6.  Toll-like receptor 2-dependent protection against pneumococcal carriage by immunization with lipidated pneumococcal proteins.

Authors:  Kristin Moffitt; Mojca Skoberne; Angela Howard; L Cristina Gavrilescu; Todd Gierahn; Scott Munzer; Bharat Dixit; Paul Giannasca; Jessica Baker Flechtner; Richard Malley
Journal:  Infect Immun       Date:  2014-03-10       Impact factor: 3.441

Review 7.  Pneumococcal Vaccines - How Many Serotypes are Enough?

Authors:  Aaradhana Singh; A K Dutta
Journal:  Indian J Pediatr       Date:  2017-09-09       Impact factor: 1.967

8.  An unusual pneumococcal sequence type is the predominant cause of serotype 3 invasive disease in South Africa.

Authors:  Kedibone M Mothibeli; Mignon du Plessis; Anne von Gottberg; Linda de Gouveia; Peter Adrian; Shabir A Madhi; Keith P Klugman
Journal:  J Clin Microbiol       Date:  2009-11-04       Impact factor: 5.948

9.  New patterns in the otopathogens causing acute otitis media six to eight years after introduction of pneumococcal conjugate vaccine.

Authors:  Janet R Casey; Diana G Adlowitz; Michael E Pichichero
Journal:  Pediatr Infect Dis J       Date:  2010-04       Impact factor: 2.129

10.  Capacity of serotype 19A and 15B/C Streptococcus pneumoniae isolates for experimental otitis media: Implications for the conjugate vaccine.

Authors:  Alison S Laufer; Jonathan C Thomas; Marisol Figueira; Janneane F Gent; Stephen I Pelton; Melinda M Pettigrew
Journal:  Vaccine       Date:  2010-01-10       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.